Matched-Pair Analysis of Survival of Never Smokers and Ever Smokers With Squamous Cell Carcinoma of the Head and Neck
- 1 October 2004
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 22 (19), 3981-3988
- https://doi.org/10.1200/jco.2004.02.133
Abstract
Purpose To compare survival rates between patients with squamous cell carcinoma of the head and neck (SCCHN) without a history of smoking (never smokers) and those with a current or previous history of smoking (ever smokers). Patients and Methods Fifty never smokers with newly diagnosed SCCHN were matched to 50 ever smokers according to sex, age, tumor site, overall stage, nodal stage, and treatment. Survival analysis was performed using Kaplan-Meier estimates. Matched-pair survival was compared using the Cox proportional hazards model. Results The never smokers had a greater overall survival (P = .020), disease-specific survival (P = .022), and recurrence-free survival (P = .016). Furthermore, matched-pair analysis demonstrated smoking was associated with a significant increase in risk of overall death (relative risk [RR] = 3.50; 95% CI, 1.14 to 10.77; P = .029), risk of death owing to disease (RR = 3.98; 95% CI, 1.11 to 14.33; P = .034), and risk of disease recurrence (RR = 3.29; 95% CI, 1.18 to 9.14; P = .023). Smoking was associated with three-fold increases in risk for overall death, death owing to disease, and recurrence after adjustment for cancer-associated symptom severity and alcohol use, but the 95% CI for these adjusted risk estimates each included the null. Conclusion Survival differed significantly between never smokers and ever smokers with SCCHN. These results are not substantively explained by differences in cancer-associated symptoms or alcohol use, but the CIs are wide and some imprecision remains. Regardless, possible fundamental differences in SCCHN between ever smokers and never smokers may exist, and further molecular characterization of these tumors is needed to determine whether biologic differences needing targeted therapies exist.Keywords
This publication has 26 references indexed in Scilit:
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Genetic susceptibility–molecular epidemiology of head and neck cancerCurrent Opinion in Oncology, 2002
- Squamous cell carcinoma of the head and neck in nonsmokers: clinical and biologic characteristics and implications for managementCurrent Opinion in Oncology, 2001
- Head and Neck Cancer in CNonsmokers: A Distinct Clinical and Molecular EntityThe Laryngoscope, 1999
- Glutathione-S-transferase polymorphisms and risk of squamous-cell carcinoma of the head and neckInternational Journal of Cancer, 1999
- Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neckCancer, 1998
- Laryngeal carcinoma in patients without a history of tobacco and alcohol useHead & Neck, 1997
- Clinical and molecular aspects of squamous cell carcinoma of the head and neck in the nonsmoker and nondrinkerCurrent Opinion in Oncology, 1997
- Histopathologic, stereologic, epidemiologic, and clinical parameters in the prognostic evaluation of squamous cell carcinoma of the oral cavityHead & Neck, 1996
- The implication of tobacco use in the young adult with head and neck cancerCancer, 1988